Metainflammation (portmanteau of metabolism + inflammation) refers to chronic, low-grade inflammatory state triggered by metabolic stress signals such as nutrient excess, lipid overload, and insulin resistance. Unlike classical inflammation responding to pathogens, metainflammation arises from metabolic dysfunction in adipose tissue, liver, muscle, and other organs, creating a state of persistent immune activation that perpetuates metabolic disease. This represents a maladaptive response where the immune system treats metabolic stressors as threats.
Metainflammation is initiated when metabolic tissues (adipose, liver, muscle) experience nutrient excess, particularly saturated fatty acids and glucose. Adipocyte hypertrophy causes hypoxia and ER stress, triggering release of inflammatory cytokines (TNF-α, IL-6, IL-1β) and recruiting macrophages that polarize toward M1 phenotype. Lipid metabolites (ceramides, diacylglycerols) activate inflammatory kinases (JNK, IKK) that phosphorylate IRS-1, blocking insulin signaling. Gut-derived LPS (from increased intestinal permeability) activates TLR4 on adipocytes and hepatocytes, amplifying inflammation. This creates self-perpetuating cycles: inflammation → insulin resistance → hyperglycemia → more inflammation. The NLRP3 inflammasome is activated by metabolic danger signals, processing pro-IL-1β into active IL-1β.
Metainflammation is the mechanistic link between obesity, insulin resistance, type 2 diabetes, cardiovascular disease, and NAFLD. It explains why metabolic diseases are inflammatory conditions and why anti-inflammatory interventions (exercise, omega-3s, fiber, caloric restriction) improve metabolic outcomes. cPNI interventions target metainflammation through dietary modification (reducing omega-6/omega-3 ratio, increasing fiber), exercise (shifting macrophage polarization), intermittent fasting (reducing nutrient excess), and addressing gut barrier dysfunction (reducing endotoxemia).
- Characterized by 2-3 fold elevation of CRP, IL-6, TNF-α (vs. 100-1000 fold in acute inflammation)
- Adipose tissue macrophages shift from M2 (10% in lean) to M1 phenotype (40% in obese)
- Circulating LPS levels 2-3x higher in obese vs. lean individuals due to endotoxemia
- Metainflammation precedes overt insulin resistance and type 2 diabetes by years
- Chronic IL-1β elevation from NLRP3 activation impairs beta-cell insulin secretion
- TNF-α directly phosphorylates IRS-1 on serine residues blocking insulin signaling
- Exercise reduces metainflammation independently of weight loss through myokine secretion
- chronic low-grade inflammation — metainflammation is the specific form of chronic inflammation driven by metabolic dysfunction
- insulin resistance — metainflammation is both cause and consequence of insulin resistance
- obesity — adipose tissue expansion triggers metainflammation through hypoxia and macrophage infiltration
- metabolic syndrome — metainflammation is the underlying inflammatory mechanism linking metabolic syndrome components
- type 2 diabetes — metainflammation contributes to beta-cell dysfunction and insulin resistance in T2D
- adipocytes — hypertrophic adipocytes secrete inflammatory cytokines initiating metainflammation
- TNF-α — TNF-α is a key metainflammatory cytokine that impairs insulin signaling
- IL-6 — IL-6 is elevated in metainflammation and contributes to insulin resistance
- IL-1β — IL-1β from NLRP3 activation impairs beta-cell function in metainflammation
- macrophages — adipose tissue macrophages polarize to M1 phenotype driving metainflammation
- M1 macrophages — M1 macrophages predominate in metabolically inflamed tissues
- NLRP3 inflammasome — metabolic danger signals activate NLRP3 producing IL-1β
- endotoxemia — gut-derived LPS contributes to metainflammation through TLR4 activation
- LPS — elevated LPS from leaky gut amplifies metainflammation
- TLR4 — TLR4 on adipocytes and hepatocytes responds to LPS driving metainflammation
- fatty acids — saturated fatty acids trigger metainflammation through TLR4 and inflammasome activation
- ER stress — nutrient excess causes ER stress in metabolic tissues contributing to metainflammation
- gut barrier — increased intestinal permeability allows endotoxemia fueling metainflammation
- omega-3 fatty acids — omega-3s reduce metainflammation through SPM production and PPAR activation
- exercise — exercise reduces metainflammation through myokine secretion and macrophage polarization